Drug Offers No CIN Protection - Renal and Urology News
Links shared publicly online about this topic.
- 588total visits
Drug Offers No CIN Protection - Renal and Urology News
CHICAGO--"Brazilian researchers report that acetylcysteine should no longer be used to prevent contrast-induced nephropathy (CIN) in patients undergoing coronary and vascular angiography.
View full resource at renalandurologynews.com
Tags: Kidney Health, Urinary System, Drug, Urology, News, Nephropathy
Most Recently Shared on January 11, 2011 at 4:08 pm By:
Drug Offers No CIN Protection: CHICAGO—Brazilian researchers report that acetylcysteine should no longer be used... http://bit.ly/hvOPXo
Advertisement
